Literature DB >> 22102026

Crystallization and preliminary X-ray crystallographic analysis of the hexameric human p97/VCP ND1 fragment in complex with the UBX domain of human FAF1.

Wonchull Kang1, Jin Kuk Yang.   

Abstract

The UBX domain of Fas-associated factor 1 (FAF1) binds to the N domain of p97/VCP, a multi-functional hexameric ATPase, and FAF1 thus inhibits the proteasome-mediated protein-degradation process assisted by p97/VCP. Here, crystallization of the hexameric p97/VCP ND1 fragment in complex with the FAF1 UBX domain is reported. Wild-type p97/VCP ND1 in complex with FAF1 UBX crystallized into very thin sheet-shaped crystals which turned out to be of poor diffraction quality. Therefore, in order to acquire a better diffraction-quality crystal, three mutants of p97/VCP ND1 were generated based on the surface-entropy reduction method. Of these, a triple mutant was the most successful in producing diffraction-quality crystals suitable for subsequent structural analysis. X-ray data were collected to 3.60 Å resolution and the crystals belonged to space group I222, with unit-cell parameters a = 166.28, b = 170.04, c = 255.99 Å. The Matthews coefficient and solvent content were estimated to be 5.78 Å(3) Da(-1) and 78.72%, respectively.
© 2011 International Union of Crystallography. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102026      PMCID: PMC3212361          DOI: 10.1107/S1744309111031794

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  19 in total

1.  The Rossmann Fourier autoindexing algorithm in MOSFLM.

Authors:  H R Powell
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-10

Review 2.  AAA+ proteins and substrate recognition, it all depends on their partner in crime.

Authors:  David A Dougan; Axel Mogk; Kornelius Zeth; Kürsad Turgay; Bernd Bukau
Journal:  FEBS Lett       Date:  2002-10-02       Impact factor: 4.124

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  Crystal structure of human FAF1 UBX domain reveals a novel FcisP touch-turn motif in p97/VCP-binding region.

Authors:  Wonchull Kang; Jin Kuk Yang
Journal:  Biochem Biophys Res Commun       Date:  2011-03-23       Impact factor: 3.575

Review 5.  FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis.

Authors:  Craig W Menges; Deborah A Altomare; Joseph R Testa
Journal:  Cell Cycle       Date:  2009-08-16       Impact factor: 4.534

6.  Crystallization and preliminary X-ray crystallographic analysis of the N domain of p97/VCP in complex with the UBX domain of FAF1.

Authors:  Hwa Young Shin; Wonchull Kang; Sang Yoon Lee; Jin Kuk Yang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-12-25

7.  Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains.

Authors:  Byron DeLaBarre; Axel T Brunger
Journal:  Nat Struct Biol       Date:  2003-08-31

8.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

9.  Conformational changes in the AAA ATPase p97-p47 adaptor complex.

Authors:  Fabienne Beuron; Ingrid Dreveny; Xuemei Yuan; Valerie E Pye; Ciaran McKeown; Louise C Briggs; Matthew J Cliff; Yayoi Kaneko; Russell Wallis; Rivka L Isaacson; John E Ladbury; Steve J Matthews; Hisao Kondo; Xiaodong Zhang; Paul S Freemont
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.